Genic제닉
123330 · KOSDAQ · ₩123330 · 제닉
- Market cap
- ₩131B
- Enterprise value
- ₩130B
- P/E
- 4.4×
- P/B
- 2.3×
- Dividend yield
- 0.0%
- ROE
- 53.0%
- Net margin
- 25.9%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−57.9% from the high
₩15,570Today: ₩16,300 – ₩16,780₩38,900
Returns
- 1W−9.6%
- 1M−32.0%
- 3M−28.5%
- 6M−42.1%
- YTD−0.8%
- 1Y−17.3%
- Volume today
- 61,306
- 0.4× the 20-day average
- Traded today
- ₩1B
- Listed shares
- 7,968,680
- EPS (12 months)
- ₩3,712
- Earnings yield 22.7%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 29 of 100 (50 is a normal day for this stock).
- MomentumWeak-32.6% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Genic stock overview
Genic (제닉, KRX: 123330) is listed on KOSDAQ, in the Chemicals sector. The company manufactures and sells cosmetics, with its main revenue coming from water-soluble hydrogel mask packs, which it sells under its own brand Celderma and also supplies through OEM and ODM manufacturing for global cosmetics customers. Its shares closed at ₩16,380 on Oct 27, 2026, up 0.74% on the day, giving it a market value of ₩131B.
Key facts
- Market cap
- ₩131B
- Sector
- Chemicals
- Latest price change
- +0.74%
- As of
- Oct 27, 2026
- Main business
- The company manufactures and sells cosmetics, with its main revenue coming from water-soluble hydrogel mask packs, which it sells under its own brand Celderma and also supplies through OEM and ODM manufacturing for global cosmetics customers.
Quick answers about Genic
- What does Genic do?
- The company manufactures and sells cosmetics, with its main revenue coming from water-soluble hydrogel mask packs, which it sells under its own brand Celderma and also supplies through OEM and ODM manufacturing for global cosmetics customers. Its product line also includes sheet masks, basic skincare, and personal care goods, sold through home shopping, duty-free shops, health and beauty stores, and online channels in Korea and overseas markets including China, Southeast Asia, Russia, Europe, and the United States.
- What is the market cap of Genic?
- The market capitalisation of Genic was ₩131B at the close on Oct 27, 2026.
- Who are the largest shareholders of Genic?
- According to the latest official filings, the largest reported holders are Soulbrain Holdings (34.55%, as of Aug 29, 2025); Mirae Asset Global Investors (4.95%, as of May 4, 2026); Medifuturs (4.37%, as of Nov 14, 2025).
- When is the next earnings report from Genic?
- Korean companies rarely announce results dates in advance. Based on when Genic filed the same report in past years, its next 3q results is expected between Nov 10, 2026 and Nov 14, 2026.
- Does the National Pension Service own Genic?
- Yes. The National Pension Service held 0.72% of Genic shares as of Dec 31, 2024.
Company profile
The company manufactures and sells cosmetics, with its main revenue coming from water-soluble hydrogel mask packs, which it sells under its own brand Celderma and also supplies through OEM and ODM manufacturing for global cosmetics customers. Its product line also includes sheet masks, basic skincare, and personal care goods, sold through home shopping, duty-free shops, health and beauty stores, and online channels in Korea and overseas markets including China, Southeast Asia, Russia, Europe, and the United States.
Written by AI from the company's latest annual report.
- Korean name
- 제닉
- Sector
- Chemicals
- Themes
- Displays
- CEO
- 허남
- Founded
- Sep 2001
- Listed
- Aug 2011
- Listed shares
- 7,968,680
- Fiscal year ends
- Month 12
- Website
- genic21.com
Similar companies
- LG Chem051910 · ₩16T₩228,500+1.56%
- Hanwha Solutions009830 · ₩5.8T₩25,850−2.45%
- Hanwha000880 · ₩4.9T₩92,700+1.64%
- SKC011790 · ₩4.1T₩83,200+5.18%
- KCC002380 · ₩3.2T₩377,000+2.45%
- Kumho Petro Chemical011780 · ₩2.6T₩106,000+3.41%
- Soulbrain357780 · ₩2.4T₩307,000+6.41%
- ISU Specialty Chemical457190 · ₩2.2T₩73,400+4.26%
Recent filings
See all- Half-year report (Jun 2026)Aug 13, 2026
- Decision on Increase in Short-Term BorrowingsJul 20, 2026
- Quarterly report (Mar 2026)May 14, 2026
- 5%+ holding reportMay 4, 2026
- Change of Department AffiliationApr 30, 2026
Titles in Korean until English translations are added.
Also known as: Genic / 제닉 / 123330 / KRX:123330
Source: KRX statistical information